Background Hormone therapy (HT) is widely used for controlling menopausal symptoms
and has also been used for the management and prevention of cardiovascular disease …

More than 5 million Americans are living with Alzheimer's disease (AD) today, and nearly
two-thirds of Americans with AD are women. This sex difference may be due to the higher …

Abstract Background Approximately 70% of Alzheimer's disease (AD) patients have co-
morbid vascular contributions to cognitive impairment and dementia (VCID); this highly …

Midlife women commonly experience changes in their cognitive function as they transition
through menopause and express concern about whether these changes represent the initial …

This guideline refers primarily to type 2 diabetes in the older person. There is limited
information on the management of type 1 diabetes in the elderly, but this is included …

Despite a large preclinical literature demonstrating neuroprotective effects of estrogen, use
of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk reduction has been …

Introduction The impact of menopausal hormone therapy (HT) on age‐associated
Alzheimer's and neurodegenerative diseases (NDDs) remains unresolved. To determine the …

Dementia is a pandemic chronic non-communicable disease. 10 in 100 women above age
65 will be diagnosed with dementia, primarily Alzheimer's disease (AD). Apart from age and …

Tubulointerstitial fibrosis is one of the most common pathological features of diabetic
nephropathy. Autophagy, an intracellular mechanism to remove damaged or dysfunctional …

Although the number of Americans dying of cardiovascular disease (CVD) continues to
increase since 2010 after decades of decrease, advances in the management of CVD have …